ENLT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Enlight Renewable Energy Ltd (ENLT) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company shows strong financial growth, positive analyst sentiment, and significant hedge fund interest. Despite no recent AI Stock Picker or SwingMax signals, the technical indicators and options data suggest bullish sentiment, making it a favorable entry point for long-term investment.
The technical indicators for ENLT are bullish. The MACD histogram is positive and expanding, suggesting upward momentum. The RSI is at 73.46, which is neutral but nearing overbought territory. Moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R2: 80.572), indicating strong upward momentum. The pre-market and post-market price changes also reflect positive sentiment.
Hedge funds are significantly increasing their positions in ENLT, with a 307.59% increase in buying over the last quarter.
Analysts have raised price targets significantly, with UBS setting a target of $93 and Barclays at $83, reflecting strong confidence in the company's growth potential.
The company's financials for Q4 2025 show robust growth, with revenue up 33.41% YoY, net income up 176.63% YoY, and EPS up 150% YoY.
The stock has a 50% chance of declining by -3.39% in the next day, -6.32% in the next week, and -3.91% in the next month based on historical candlestick patterns.
No recent congress trading data or insider buying trends to further validate sentiment.
Enlight Renewable Energy Ltd reported strong financial growth in Q4 2025. Revenue increased by 33.41% YoY to $152.36 million, net income surged by 176.63% YoY to $14.26 million, and EPS rose by 150% YoY to 0.1. Gross margin improved slightly to 48.61%, up 0.70% YoY, indicating efficient operations.
Analysts are bullish on ENLT. UBS raised its price target to $93 from $65, citing strong demand for clean energy and the company's ability to meet future capacity goals. Barclays increased its target to $83, maintaining an Overweight rating. Mizuho raised its target to $37 but kept an Underperform rating, citing concerns about regulatory complexity. Overall, the sentiment leans positive with significant upside potential.
